Pakistan to purchase Covid-19 vaccine from China's Sinopharm

Pakistan has decided to pre-book a Covid-19 vaccine from Chinese state-owned company Sinopharm for emergency use for healthcare workers

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Representational image of a Covid-19 vaccine
IANS Islamabad
2 min read Last Updated : Dec 31 2020 | 2:55 PM IST

Pakistan has decided to pre-book a Covid-19 vaccine from Chinese state-owned company Sinopharm for emergency use for healthcare workers, the Ministry of National Health Services, Regulations and Coordination said on Thursday.

In a meeting of a Special Cabinet Committee constituted as an oversight body for procurement of the Covid-19 vaccine, it was decided that Pakistan will follow the practice of most of the countries to pre-book the vaccine based on preliminary results in order to ensure its timely availability of the vaccines, Xinhua news agency quoted a Ministry statement as saying.

It was decided that the Pakistani government will provide free Covid-19 vaccine to all frontline health workers in the first quarter of 2021, after procuring it from the Chinese company.

The committee was informed of the deliberations of an expert committee formed by Drug Regulatory Authority of Pakistan (DRAP) who is in process of reviewing and analysing available data from clinical studies performed so far.

It was also decided that other manufacturers of Covid-19 vaccine will continue to be engaged in future bookings for the remaining phases of vaccination, based on further data and availability.

The committee reiterated that the private sector will also be encouraged to approach DRAP and follow the laid down procedures for emergency use authorization of any available and safe vaccine.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusPakistan China

First Published: Dec 31 2020 | 2:51 PM IST

Next Story